Claims for Patent: 8,217,227

Summary for Patent: 8,217,227

Title:	Recombinant DNA constructs and methods for controlling gene expression
Abstract:	The present invention provides molecular constructs and methods for use thereof, including constructs including heterologous miRNA recognition sites, constructs for gene suppression including a gene suppression element embedded within an intron flanked on one or on both sides by non-protein-coding sequence, constructs containing engineered miRNA or miRNA precursors, and constructs for suppression of production of mature microRNA in a cell. Also provided are transgenic plant cells, plants, and seeds containing such constructs, and methods for their use. The invention further provides transgenic plant cells, plants, and seeds containing recombinant DNA for the ligand-controlled expression of a target sequence, which may be endogenous or exogenous. Also disclosed are novel miRNAs and miRNA precursors from crop plants including maize and soy.
Inventor(s):	Allen; Edwards (O\'Fallon, MO), Gilbertson; Larry A. (Chesterfield, MO), Huang; Shihshieh (Woodland, CA), Malvar; Thomas (North Stonington, CT), Roberts; James K. (Chesterfield, MO)
Assignee:	Monsanto Technology LLC (St. Louis, MO)
Application Number:	11/545,072
Patent Claims:	1. A method for suppressing expression of a target RNA in a specific cell of a plant, comprising transcribing in said plant a recombinant DNA construct comprising a promoter functional in a plant cell and operably linked to DNA that transcribes to RNA comprising: (a) at least one exogenous miR408 miRNA recognition site that is recognizable by a mature miR408 miRNA that is expressed in a specific cell of a plant, and; (b) target RNA to be suppressed in said specific cell, wherein said mature mir408 miRNA guides cleavage of said target RNA in said specific cell, and wherein said target RNA is not an RNA from an endogenous target gene for miR408 miRNA, whereby expression of said target RNA is suppressed in said specific cell relative to its expression in cells lacking expression of said mature miR408 miRNA. 2. The method of claim 1, wherein said recombinant DNA construct further comprises a gene expression element for expressing at least one gene of interest, and wherein said expression of said target RNA is suppressed with concurrent expression of said at least one gene of interest in said specific cell. 3. The method of claim 1, wherein said plant is a crop plant. 4. The method of claim 1, wherein said target RNA comprises a gene suppression element embedded in an intron flanked on one or on both sides by non-protein-coding DNA. 5. A method of providing at least one altered plant tissue, comprising: (a) providing a transgenic plant comprising a regenerated plant prepared from a transgenic plant cell having in its genome a recombinant DNA construct comprising a promoter functional in a plant cell and operably linked to DNA that transcribes to RNA comprising at least one exogenous miR408 miRNA recognition site that is recognizable by a mature miR408 miRNA that is expressed in a specific cell of a plant, and target RNA to be suppressed in said specific cell, or a progeny plant of said regenerated plant comprising said recombinant DNA construct, and wherein said target RNA is not an RNA from an endogenous target gene for miR408 miRNA; and (b) transcribing said recombinant DNA construct in at least one tissue of said transgenic plant, whereby an altered trait in said at least one tissue results, relative to tissue wherein said recombinant DNA construct is not transcribed, said altered trait being selected from: (i) improved abiotic stress tolerance; (ii) improved biotic stress tolerance; (iii) improved resistance to a pest or pathogen of said plant; (iv) modified primary metabolite composition; (v) modified secondary metabolite composition; (vi) modified trace element, carotenoid, or vitamin composition; (vii) improved yield; (viii) improved ability to use nitrogen or other nutrients; (ix) modified agronomic characteristics; (x) modified growth or reproductive characteristics; and (xi) improved harvest, storage, or processing quality. 6. The method of claim 5, wherein said transgenic plant is a crop plant. 7. The method of claim 1, wherein said miR408 recognition site is selected from the group consisting of SEQ ID NO:206, SEQ ID NO:207, SEQ ID NO:208, SEQ ID NO:209, and SEQ ID NO:210.

Details for Patent 8,217,227

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-02-26